Nabin K Shrestha1, Jugnu Shrestha2, Angela Everett2, Donald Carroll3, Steven M Gordon2, Robert S Butler4, Susan J Rehm2. 1. Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH 44195, USA shrestn@ccf.org. 2. Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH 44195, USA. 3. Cleveland Clinic Home Infusion Pharmacy, Cleveland Clinic, Cleveland, OH 44195, USA. 4. Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, USA.
Abstract
OBJECTIVES: The need for indwelling vascular access for outpatient parenteral antimicrobial therapy (OPAT) places patients at risk of vascular access complications. The purpose of this study was to describe vascular access complications during OPAT at home, and identify factors associated with their occurrence. METHODS: All OPAT courses carried out at home for patients at Cleveland Clinic in 2013 were identified from the institution's OPAT registry. The first OPAT course per patient was included. Vascular access complications that occurred during the treatment course were abstracted from the electronic medical record. Only complications that triggered a clinical intervention were included. RESULTS: The 1461 included OPAT courses encompassed 33,579 OPAT days of treatment. One-hundred-and-forty-four vascular access complications occurred in 131 OPAT courses (9% of OPAT courses, 4.29 complications per 1000 OPAT days). The most common complication was occlusion (53% of all complications). Hickman catheters [incidence rate ratio (IRR) 0.20, 95% CI 0.03-0.63] and indwelling ports (IRR 0.25, 95% CI 0.04-0.78) were associated with lower complication rates than peripherally inserted central catheters, as was increasing age (IRR 0.99, 95% CI 0.98-1.00). Log OPAT duration (IRR 1.60, 95% CI 1.28-2.03), female sex (IRR 1.62, 95% CI 1.16-2.28) and injection drug use (IRR 3.32, 1.16-7.46) were associated with increased risk of vascular access complications. CONCLUSIONS: Nine percent of OPAT courses at home have at least one vascular access complication requiring clinical intervention. Longer OPAT duration, younger age, female sex and injection drug use are associated with increased risk of vascular access complications.
OBJECTIVES: The need for indwelling vascular access for outpatient parenteral antimicrobial therapy (OPAT) places patients at risk of vascular access complications. The purpose of this study was to describe vascular access complications during OPAT at home, and identify factors associated with their occurrence. METHODS: All OPAT courses carried out at home for patients at Cleveland Clinic in 2013 were identified from the institution's OPAT registry. The first OPAT course per patient was included. Vascular access complications that occurred during the treatment course were abstracted from the electronic medical record. Only complications that triggered a clinical intervention were included. RESULTS: The 1461 included OPAT courses encompassed 33,579 OPAT days of treatment. One-hundred-and-forty-four vascular access complications occurred in 131 OPAT courses (9% of OPAT courses, 4.29 complications per 1000 OPAT days). The most common complication was occlusion (53% of all complications). Hickman catheters [incidence rate ratio (IRR) 0.20, 95% CI 0.03-0.63] and indwelling ports (IRR 0.25, 95% CI 0.04-0.78) were associated with lower complication rates than peripherally inserted central catheters, as was increasing age (IRR 0.99, 95% CI 0.98-1.00). Log OPAT duration (IRR 1.60, 95% CI 1.28-2.03), female sex (IRR 1.62, 95% CI 1.16-2.28) and injection drug use (IRR 3.32, 1.16-7.46) were associated with increased risk of vascular access complications. CONCLUSIONS: Nine percent of OPAT courses at home have at least one vascular access complication requiring clinical intervention. Longer OPAT duration, younger age, female sex and injection drug use are associated with increased risk of vascular access complications.
Authors: Sara C Keller; Sara E Cosgrove; Alicia I Arbaje; Rachel Huai-En Chang; Amanda Krosche; Deborah Williams; Ayse P Gurses Journal: Jt Comm J Qual Patient Saf Date: 2019-08-22
Authors: Nabin K Shrestha; Caitlin Blaskewicz; Steven M Gordon; Angela Everett; Susan J Rehm Journal: Open Forum Infect Dis Date: 2020-10-03 Impact factor: 3.835
Authors: Taylor Morrisette; Matthew A Miller; Brian T Montague; Gerard R Barber; R Brett McQueen; Martin Krsak Journal: Open Forum Infect Dis Date: 2019-06-05 Impact factor: 3.835
Authors: Thomas P Lodise; Christina Palazzolo; Kerry Reksc; Elizabeth Packnett; Mark Redell Journal: Open Forum Infect Dis Date: 2019-11-04 Impact factor: 3.835
Authors: Catherine Li; Nicholas J Mercuro; Ryan W Chapin; Howard S Gold; Christopher McCoy Journal: Antimicrob Agents Chemother Date: 2021-08-17 Impact factor: 5.191
Authors: Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton Journal: JAC Antimicrob Resist Date: 2019-08-26